Exhibition
Phase II Data of Cadonilimab Regimen as Neoadjuvant Therapy for Resectable Gastric Cancer Presented at ESMO Asia 2025
HONG KONG, Dec. 9, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that data from the Phase II study (COMPASSION-25) for its first-in-class PD-1/CTLA-4 bispecific antibody, cadonilimab, in combination with SOX regimen (oxaliplatin + tegafur/gimeracil/oteracil) as n...
2025-12-09 15:50
865
Moutai Cultural Exhibition Ignites U.S. Audience with Immersive Journey Through a Century of Cultural Heritage
SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ -- From December 7 to 8, Kweichow Moutai celebrated a dual milestone - the 110th anniversary of its award-winning debut at the 1915 Panama-Pacific International Exposition and the 10th anniversary of San Francisco Moutai Day - through a dynamic series of e...
2025-12-09 00:13
1070
STRADVISION Announces Next Phase of Cloud-Driven Innovation in Collaboration with AWS
- Head of Data Innovation Center presents STRADVISION's next roadmap at
AWS re:Invent
SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- STRADVISION
2025-12-09 00:00
1010
Autocrypt Announces Product Release of Post-Quantum PKI Product, Pioneering PQC-enabled Solutions for Automotive OEMs
SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Leading automotive cybersecurity solutions provider AUTOCRYPT announced onDecember 8, 2025, the launch of "AutoCrypt PKI-Vehicles," a new next-generation Public Key Infrastructure (PKI) solution supporting ML-DSA, a post-quantum digital signature ...
2025-12-08 21:00
904
Yantai offers global bay areas a paradigm of low-carbon transformation
YANTAI, China, Dec. 8, 2025 /PRNewswire/ -- On December 4, the 2025 Shandong Green Low-carbon High-quality Development Conference was held in Yantai,Shandong province. Against the backdrop of the fifth anniversary ofChina's 'dual carbon' goals, Yantai's achievements—as one of the country's first ...
2025-12-08 16:52
920
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 10:08
1469
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 08:15
961
Neurophet Participates RSNA 2025, Showcased Real-World Clinical Use Cases of 'Neurophet AQUA AD'
* Demonstrated brain imaging analysis solutions, including 'Neurophet AQUA AD,' which enables monitoring of adverse effects associated with Alzheimer's disease treatments * Highlighted clinical cases that improved the safety of anti-amyloid therapy administration during an AI Theater session ...
2025-12-05 22:00
3231
ANTA Makes Its Debut at The Running Event, Unveils New Tech Lineup with Kenenisa Bekele
SAN ANTONIO, Dec. 4, 2025 /PRNewswire/ -- Founded in 1991, ANTA Sports Products Limited has built a robust multi-brand portfolio over the past three decades. Today, it stands among the world' top three sportswear companies. Staying true to its mission of "bring the transcendent sports spirit into...
2025-12-05 12:25
1515
Blueprint to offer new opportunity
China's 15th Five-Year Plan set to bring about fresh momentum for global growth
BEIJING, Dec. 4, 2025 /PRNewswire/ -- A news report from chinadaily.com.cn:
2025-12-05 09:56
1589
TUTTOFOOD 2026 SET TO WELCOME OVER 100,000 VISITORS TO MILAN
With 80% of exhibitors confirmed - 30% from abroad - and more than 70 countries represented, participation is set to boost by 15–20% over the last editions MILAN, Dec. 5, 2025 /PRNewswire/ -- TUTTOFOOD, Southern Europe's leading food business platform, taking place from11 to 14 May 2026 in Mi...
2025-12-05 08:01
1590
UMED Wins CES Innovation Awards® 2026, Redefining Bladder Care with World's First Automated Irrigation System
Transforming bladder care from hospital-centered procedures to accessible, data-driven digital urology SEOUL, South Korea, Dec. 4, 2025 /PRNewswire/ -- UMED Inc, an AI-driven urology-focused healthcare startup, announced that its automated bladder irrigation system, UroRinse™ Light, has been nam...
2025-12-04 15:08
927
High Response in Bladder Cancer: Immvira Announced Its MVR-T3011 Latest Clinical Results in BCG-Unresponsive Bladder Cancer Patients at 2025 Annual Meeting of the Society of Urologic Oncology
SUZHOU, China, Dec. 3, 2025 /PRNewswire/ -- On December 3, 2025 (local time in Arizona, USA), ImmVira Group ("ImmVira" or the "Company") announced a poster presentation at the 26th Annual Meeting of the Society of Urologic Oncology (SUO 2025). The presentation featured the latest interim clinical...
2025-12-04 08:00
892
Korea's Startups Poised for a Landmark Season as COMEUP 2025 and CES 2026 Draw Near
SEOUL, South Korea, Dec. 3, 2025 /PRNewswire/ -- Korea is preparing for a defining season in global innovation, asSeoul readies for COMEUP 2025—hosted by the Ministry of SMEs and Startups—and Korean entrepreneurs mark final preparations for their annual journey toLas Vegas for CES 2026. The two s...
2025-12-04 02:00
1571
ImpriMed to Present Ex Vivo Drug Sensitivity Data in Acute Myeloid Leukemia in Oral Presentation at American Society of Hematology Annual Meeting
Studies Demonstrate xCellSense® Platform's Ability to Predict Clinical Response
and Enable Patient Stratification for Drug Development.
PALO ALTO, Calif., Dec. 3, 2025 /PRNewswire/ -- ImpriMed
2025-12-04 01:00
969
The 110-Year Trans-Pacific Cultural Dialogue: Moutai's Dual Anniversary Brand Celebration Prepares for Grand Opening in the United States
SAN FRANCISCO, Dec. 2, 2025 /PRNewswire/ -- In commemoration of the 110th anniversary of Moutai's debut and award-winning at the Panama-Pacific International Exposition and the 10th anniversary of San Francisco Moutai Day, the Kweichow Moutai delegation led by Group Vice General ManagerZhang Guic...
2025-12-03 12:00
824
Waterdrop Wins 2025 Global Best Case Brands Award, Empowering Inclusive Protection Through Technological Innovation
BEIJING, Dec. 2, 2025 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) was honored with the Global Best Case Brands Award at the 3rd International Conference on Management Change and Sustainable Development (MC&SD). Selected from more than 100 nominated companies, Waterdrop stood out for its significan...
2025-12-03 11:32
2286
Natural Field Releases "Ashwagandha White Paper" and Landmark Liposome Research Achievements at 2025 FTA (Food Research Exchange Super Ingredients Conference)
HANGZHOU, China, Dec. 2, 2025 /PRNewswire/ -- Against the backdrop of the accelerated upgrading of the global functional nutrition industry, technology-driven ingredient enterprises are increasingly emerging as the core force of the industrial chain. InNovember 2025, the FTA (Food Research Exchan...
2025-12-03 00:00
1233
Lunit to Highlight New AI Evidence in Cancer Screening and Breast Density-Driven Risk Modeling at RSNA 2025
Eight oral presentations and six posters demonstrate advances in mammography, DBT performance, and density-informed risk modeling SEOUL, South Korea, Dec. 2, 2025 /PRNewswire/ -- Lunit, a leading provider of AI for cancer diagnostics and precision oncology, today announced it will present 14 stu...
2025-12-02 22:10
3092
Tsinghua art academy AADTHU hosts global conference in Milan exploring art & design education
BEIJING, Dec. 2, 2025 /PRNewswire/ -- This is a report from China.org.cn: The Academy of Arts & Design, Tsinghua University (AADTHU) held a major academic conference in Milan, Italy, on Nov. 15-16, under the theme "Future Context: A New Paradigm for Art and Design Education." The Tsinghua Intern...
2025-12-02 22:00
776
Week's Top Stories
Most Reposted
ABL Bio Receives Upfront Payment for License, Research and Collaboration Agreement for Grabody Platform and Equity Investment from Lilly
[Picked up by 278 media titles]
2025-12-26 12:55Vietnam's Newest EDM Destination, APLUS SAIGON, Debuts With Star-Studded Soft Opening Weekends Featuring Dombresky and Argy
[Picked up by 273 media titles]
2025-12-30 20:12
ACEN completes transition to 100% renewable energy
[Picked up by 273 media titles]
2025-12-29 18:53iQIYI LAND Yangzhou to Open on February 8, Marking New Chapter in China's Immersive Entertainment Scene
[Picked up by 269 media titles]
2026-01-01 10:00
CYFIRMA's 2025 Impact Recap Showcases DeCYFIR, Preemptive External Threat Landscape Management Platform, Delivering Measurable Global Defense Against Emerging Threats
[Picked up by 263 media titles]
2025-12-29 09:00
